Predictors of response to pacritinib therapy and survival among 60 Mayo Clinic patients with myelofibrosis treated outside of clinical trials

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2025-03-20
DOI
https://doi.org/10.3324/haematol.2025.287576
Citations
1
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictors of response to pacritinib therapy and survival among 60 Mayo Clinic patients with myelofibrosis treated outside of clinical trials

Naseema Gangat, Cecilia Y. Arana Yi, Aref Al‐Kali, Ayalew Tefferi et al.
1 citations
Haematologica
Myeloproliferative Neoplasms: Diagnosis and Treatment
1.63
article

Predictors of response to pacritinib therapy and survival among 60 Mayo Clinic patients with myelofibrosis treated outside of clinical trials

Naseema Gangat, Cecilia Y. Arana Yi, Aref Al‐Kali, Ayalew Tefferi, Maymona Abdelmagid, Animesh Dev Pardanani, James M. Foran, Jeanne Palmer, Mehrdad Hefazi, Kebede H. Begna
article en
1 citations

Abstract

No abstract available for this paper.
HaematologicaVol. 110(9)
Jacksonville College (US), WinnMed (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US)
Zero hunger
Openalex Percentile: Top 19%
Myeloproliferative Neoplasms: Diagnosis and Treatment
1.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.